The weekly litigation news digest is live. Subscribe now

IP Verse

Bristol-Myers Squibb Company v. Azurity Pharmaceuticals, Inc. - 1:25-cv-01558

Bristol-Myers Squibb Company v. Azurity Pharmaceuticals, Inc. (Case No. 1:25-cv-01558), filed on Dec 23, 2025 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:25-cv-01558
Filing Date
Dec 23, 2025
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Bristol-Myers Squibb Company -
Pfizer Inc. -
Azurity Pharmaceuticals, Inc. -

Patents Involved

There is a single patent involved in this case.

Application NumberPatent Number
-US9326945B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Dec 29, 2025Summons Issued as to Azurity Pharmaceuticals, Inc. on 12/29/2025. (slk) (Entered: 12/29/2025)PACER Document
Dec 23, 2025Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bristol-Myers Squibb Company, Pfizer Inc. (slk) (Entered: 12/29/2025)PACER Document
Dec 23, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,326,945 B2. (slk) (Entered: 12/29/2025)PACER Document
Dec 23, 2025Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 13, 2025. Date of Expiration of Patent: August 24, 2031 (with applicable pediatric exclusivity).Thirty Month Stay Deadline: 5/13/2028. (slk) (Entered: 12/29/2025)PACER Document
Dec 23, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (slk) (Entered: 12/29/2025)PACER Document
Dec 23, 2025COMPLAINT filed against Azurity Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4865462.) - filed by Pfizer Inc., Bristol-Myers Squibb Company. (Attachments: # 1 Exhibit A-F, # 2 Civil Cover Sheet)(slk) (Entered: 12/29/2025)PACER Document